Health Condition 1: O141- Severe pre-eclampsia
Conditions
Interventions
Intervention1: nil: nil
Sponsors
Post Graduate Institute of Medical Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: severely pre eclamptic women, 30-38 weeks of gestation who are scheduled to receive MgSO4
Exclusion criteria
Exclusion criteria: Women with chronic hypertension, eclampsia, chronic renal disease, hyperthyroidism, twin gestation, seizure disorder, noninsulin dependent diabetes mellitus, severe anemia, autoimmune disorders and those with ocular injuries or prior ocular surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change in peak ratio after magnesium sulphate administration at 60 minsTimepoint: The change in peak ratio after magnesium sulphate administration at 60 mins | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The baseline ophthalmic artery indices (resistive index, pulsatility index and peak ratio) in severely pre eclamptic women 2. The change in resistive index after magnesium sulphate administration 3. The change in pulsalitiy index after magnesium sulphate administration Timepoint: 0mins, 60 mins and 24 hours | — |
Countries
India
Contacts
Public ContactAnudeep Jafra
Post Graduate Institute of Medical Education and Research
Outcome results
None listed